A Double-blind, Randomized, Placebo-controlled, Double-dummy, Four-way Crossover Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 22 Oct 2018
Price : $35 *
At a glance
- Drugs Daridorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Idorsia Pharmaceuticals
- 12 Oct 2018 Status changed from recruiting to completed.
- 03 Oct 2018 Status changed from not yet recruiting to recruiting.
- 15 Aug 2018 Planned initiation date changed from 1 Aug 2018 to 31 Aug 2018.